Quick Search

 

 


 

 

Result Summary for 113160

Result Summary
Protocol ID: 113160
Clinical Study ID: SIR113160
Official Title: A Phase II, Randomized, Placebo-Controlled, Double-Blind, Multiple-Dose Clinical Study to Assess the Safety and Pharmacokinetics of SRT2104 in Type 2 Diabetic Human Subjects
Phase: phase 2
Study Indications or Diseases:
  • Diabetes Mellitus, Type 2
Generic Name: SRT2104
Trade/Product Name: SRT2104
Approved Drug Label: http://www.gsk.com/products.html
Results Summary: Click here to download result summary. Click here to download result summary.
Citations:

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.